These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

576 related items for PubMed ID: 22639934

  • 1. Formulation, characterization and in vitro-in vivo evaluation of flurbiprofen-loaded nanostructured lipid carriers for transdermal delivery.
    Kawadkar J, Pathak A, Kishore R, Chauhan MK.
    Drug Dev Ind Pharm; 2013 Apr; 39(4):569-78. PubMed ID: 22639934
    [Abstract] [Full Text] [Related]

  • 2. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration.
    Song A, Zhang X, Li Y, Mao X, Han F.
    Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).
    Garg NK, Sharma G, Singh B, Nirbhavane P, Tyagi RK, Shukla R, Katare OP.
    Int J Pharm; 2017 Jan 30; 517(1-2):413-431. PubMed ID: 27956192
    [Abstract] [Full Text] [Related]

  • 5. Nanostructured lipid carriers for the topical delivery of tretinoin.
    Ghate VM, Lewis SA, Prabhu P, Dubey A, Patel N.
    Eur J Pharm Biopharm; 2016 Nov 30; 108():253-261. PubMed ID: 27519827
    [Abstract] [Full Text] [Related]

  • 6. Pluronic lecithin organogel as a topical drug delivery system.
    Pandey M, Belgamwar V, Gattani S, Surana S, Tekade A.
    Drug Deliv; 2010 Jan 30; 17(1):38-47. PubMed ID: 22747074
    [Abstract] [Full Text] [Related]

  • 7. Lipid nanoparticles for transdermal delivery of flurbiprofen: formulation, in vitro, ex vivo and in vivo studies.
    Bhaskar K, Anbu J, Ravichandiran V, Venkateswarlu V, Rao YM.
    Lipids Health Dis; 2009 Feb 26; 8():6. PubMed ID: 19243632
    [Abstract] [Full Text] [Related]

  • 8. Docetaxel-nicotinamide complex-loaded nanostructured lipid carriers for transdermal delivery.
    Fan X, Chen J, Shen Q.
    Int J Pharm; 2013 Dec 31; 458(2):296-304. PubMed ID: 24177313
    [Abstract] [Full Text] [Related]

  • 9. Enhanced transdermal delivery of lornoxicam by nanostructured lipid carrier gels modified with polyarginine peptide for treatment of carrageenan-induced rat paw edema.
    Gao S, Tian B, Han J, Zhang J, Shi Y, Lv Q, Li K.
    Int J Nanomedicine; 2019 Dec 31; 14():6135-6150. PubMed ID: 31447556
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Nanostructured lipid carriers as a delivery system of biochanin A.
    Wang Q, Cheng H, Zhou K, Wang L, Dong S, Wang D, Chen W.
    Drug Deliv; 2013 Nov 31; 20(8):331-7. PubMed ID: 24111887
    [Abstract] [Full Text] [Related]

  • 12. Potential use of nanostructured lipid carriers for topical delivery of flurbiprofen.
    González-Mira E, Nikolić S, García ML, Egea MA, Souto EB, Calpena AC.
    J Pharm Sci; 2011 Jan 31; 100(1):242-51. PubMed ID: 20575052
    [Abstract] [Full Text] [Related]

  • 13. Development of a quercetin-loaded nanostructured lipid carrier formulation for topical delivery.
    Chen-yu G, Chun-fen Y, Qi-lu L, Qi T, Yan-wei X, Wei-na L, Guang-xi Z.
    Int J Pharm; 2012 Jul 01; 430(1-2):292-8. PubMed ID: 22486962
    [Abstract] [Full Text] [Related]

  • 14. Design, characterization and skin permeating potential of Fluocinolone acetonide loaded nanostructured lipid carriers for topical treatment of psoriasis.
    Pradhan M, Singh D, Murthy SN, Singh MR.
    Steroids; 2015 Sep 01; 101():56-63. PubMed ID: 26049018
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A new topical formulation for psoriasis: development of methotrexate-loaded nanostructured lipid carriers.
    Pinto MF, Moura CC, Nunes C, Segundo MA, Costa Lima SA, Reis S.
    Int J Pharm; 2014 Dec 30; 477(1-2):519-26. PubMed ID: 25445970
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Physicochemical characterization and in vivo bioluminescence imaging of nanostructured lipid carriers for targeting the brain: apomorphine as a model drug.
    Hsu SH, Wen CJ, Al-Suwayeh SA, Chang HW, Yen TC, Fang JY.
    Nanotechnology; 2010 Oct 08; 21(40):405101. PubMed ID: 20823498
    [Abstract] [Full Text] [Related]

  • 19. Characterization and evaluation of nanostructured lipid carrier as a vehicle for oral delivery of etoposide.
    Zhang T, Chen J, Zhang Y, Shen Q, Pan W.
    Eur J Pharm Sci; 2011 Jun 14; 43(3):174-9. PubMed ID: 21530654
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.